The first batch of coronavirus vaccine from the US company Johnson & Johnson could come for emergency use in January.
Ruxandra Draghia-Akli, head of the company’s public health research and development division, made the remarks at a presentation at the World Health Conference.
The U.S. pharmaceutical company has previously expressed similar hopes about getting the corona vaccine. Now the head of the company’s public health research and development department says the same thing.
The name of Johnson & Johnson’s possible vaccine is ‘Janssen‘. The other vaccine requires two doses, but the vaccine requires only one dose.
Johnson & Johnson said last Friday that their large-scale coronavirus vaccine tests were starting again.
According to CNN, Johnson & Johnson’s vaccination test was postponed earlier this month after a volunteer fell ill during the vaccination test.
Johnson & Johnson announced their decision to suspend their vaccination test on 12 October after one of the participating volunteers fell ill. Johnson & Johnson said Friday it was not known why the man fell ill.
Johnson & Johnson’s ticker test began on September 23. The target is to include 60,000 people in eight countries. The company hopes to get the preliminary results of the vaccine test by the end of this year.
The Johnson & Johnson vaccine is the fourth in the final immunization test or third stage test in the United States. The Johnson & Johnson test is the largest in terms of vaccine testing.
Testing of the British company AstraZeneca vaccine has recently resumed in the United States. The tick test was also discontinued after news of a volunteer’s illness.
The news agency Reuters reported that the elderly are most at risk of complications from coronavirus infection. The potential vaccine of Oxford University and the pharmaceutical company AstraZeneca are able to develop the necessary immunity in the body of those elderly people.
Not only that, but the vaccine is also working in the body of young people. AstraZeneca made the claim on Monday.
The whole world is expecting an effective and safe vaccine to deal with the ongoing epidemic. That hope is becoming brighter in this news.